Growth Metrics

Nephros (NEPH) Cash from Financing Activities (2016 - 2025)

Nephros has reported Cash from Financing Activities over the past 16 years, most recently at -$1000.0 for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$1000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was -$5000.0 (changed 0.0% YoY), and the annual figure for FY2025 was -$5000.0, changed 0.0%.
  • Cash from Financing Activities for Q4 2025 was -$1000.0 at Nephros, up from -$2000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for NEPH hit a ceiling of $281000.0 in Q1 2022 and a floor of -$111000.0 in Q4 2022.
  • Median Cash from Financing Activities over the past 5 years was -$2000.0 (2023), compared with a mean of $10111.1.
  • Peak annual rise in Cash from Financing Activities hit 9466.67% in 2022, while the deepest fall reached 250.0% in 2022.
  • Nephros' Cash from Financing Activities stood at -$37000.0 in 2021, then tumbled by 200.0% to -$111000.0 in 2022, then surged by 97.3% to -$3000.0 in 2023, then surged by 66.67% to -$1000.0 in 2024, then changed by 0.0% to -$1000.0 in 2025.
  • The last three reported values for Cash from Financing Activities were -$1000.0 (Q4 2025), -$2000.0 (Q3 2025), and -$1000.0 (Q2 2025) per Business Quant data.